Arbutus Biopharma: Q1 Earnings Insights

  Arbutus Biopharma (NASDAQ:ABUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

 

Arbutus Biopharma (NASDAQ:ABUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Arbutus Biopharma beat estimated earnings by 31.25%, reporting an EPS of $-0.11 versus an estimate of $-0.16.

Revenue was up $10.47 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 4.75% drop in the share price the next day.

Here’s a look at Arbutus Biopharma’s past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.19 -0.24 -0.22 -0.23
EPS Actual -0.15 -0.24 -0.23 -0.21
Revenue Estimate 2.87M 2.38M 2.12M 3.31M
Revenue Actual 3.21M 3.34M 2.33M 2.11M

To track all earnings releases for Arbutus Biopharma visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts